Barclays »

Bridgebio Pharma shares owned by Barclays

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Barclays

Quarter filed Position value Share count Share price at filing
2025-09-30 $22k 16k 1.40
2023-09-30 $673k 700k 0.96

More positions owned by Barclays

Microsoft Corporation (MSFT)
SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Ishares Tr Fund (IWM)
Apple (AAPL)
Tesla Opt Put Option (TSLA)
Amazon Opt Call Option (AMZN)
Alphabet Opt Call Option (GOOGL)
Broadcom Opt Call Option (AVGO)
Facebook Inc cl a (META)
Ishares Tr Opt Call Option (HYG)
JPMorgan Chase & Co. (JPM)
Alphabet Opt Put Option (GOOG)
Berkshire Hathaway Inc Del Opt Put Option (BRK.B)

View all positions for Barclays

Top funds holding Bridgebio Pharma

Wolverine Asset Management
Linden Advisors
Weiss Asset Management LP[1
Tenor Capital Management
Citadel Advisors
Graham Capital Management
Balyasny Asset Management
Ing Investment Management
Capstone Investment Advisors
Lazard Asset Management
683 Capital Management
Lord, Abbett & Co
M&G
Morgan Stanley
State Street Corporation

View all funds holding Bridgebio Pharma